twitter Facebook

If you are a subscriber, you can login here

In tune. Informed. Indispensable.

Hipgnosis acquires catalogue from Giorgio Tuinfort

Hipgnosis Songs Fund Limited (“Hipgnosis” or the “Company”)

Acquisition of Music Catalogue

The Board of Hipgnosis Songs Fund Limited and its Investment Adviser, The Family (Music) Limited, are pleased to announce that the Company has acquired a music catalogue from Giorgio Tuinfort. In addition to winning multiple Grammy Awards, Giorgio Tuinfort has written 23 number 1 singles and has won theprestigious BMI Songwriter Award an unprecedented 30 times. The Company has acquired 100% of Giorgio Tuinfort’s interest in the catalogue.

The catalogue comprises 182 songs in total, including 23 number 1 songs. It includes more than 15 UK Top 10 singles with David Guetta, including 6 number 1s. In addition to David Guetta, the catalogue includes songs for Gwen Stefani, Sia, Emeli Sandé, Nicki Minaj, Afrojack, Martin Garrix, Rihanna, Avicii, Usher,, Akon and Lionel Richie.

Merck Mercuriadis, Founder of The Family (Music) Limited and Hipgnosis Songs Fund Limited, said:

“Giorgio is arguably the most underrated hit songwriter of the last 20 years. He could just as easily be composing a piano concerto as co-writing magnificent pop like “The Sweet Escape” for Gwen Stefani or “One Last Time” for Ariana Grande. He has quietly been the partner of choice for everyone from Akon to David Guetta and has been instrumental, literally, in their incredible successes. For me “Titanium” is as sophisticated as pop can get. Giorgio’s work is sublime.”

Giorgio Tuinfort, said:

“To entrust someone with your musical life work is like entrusting someone with your child; only a person with integrity and high values can bear that responsibility. That’s Merck to me. A visionary, but most of all a man who recognises the value of one of mankind’s greatest gifts; music. My catalogue is simply in the best hands it could be.”

Submit news or a press release

Want to add your news or press release? Email us

Two week FREE trial
device: pc